347 related articles for article (PubMed ID: 34976821)
1.
Havaei SM; Aucoin MG; Jahanian-Najafabadi A
Front Oncol; 2021; 11():781800. PubMed ID: 34976821
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of Immunotoxins Containing
Mazor R; Pastan I
Front Immunol; 2020; 11():1261. PubMed ID: 32695104
[TBL] [Abstract][Full Text] [Related]
3. Targeted Diphtheria Toxin-Based Therapy: A Review Article.
Shafiee F; Aucoin MG; Jahanian-Najafabadi A
Front Microbiol; 2019; 10():2340. PubMed ID: 31681205
[TBL] [Abstract][Full Text] [Related]
4. Immunotoxins in cancer therapy: Review and update.
Akbari B; Farajnia S; Ahdi Khosroshahi S; Safari F; Yousefi M; Dariushnejad H; Rahbarnia L
Int Rev Immunol; 2017 Jul; 36(4):207-219. PubMed ID: 28282218
[TBL] [Abstract][Full Text] [Related]
5. Humanized immunotoxins: a new generation of immunotoxins for targeted cancer therapy.
Mathew M; Verma RS
Cancer Sci; 2009 Aug; 100(8):1359-65. PubMed ID: 19459847
[TBL] [Abstract][Full Text] [Related]
6. New insights on
Morgan RN; Saleh SE; Farrag HA; Aboshanab KM
Ther Deliv; 2023 Jan; 14(1):31-60. PubMed ID: 36950853
[TBL] [Abstract][Full Text] [Related]
7. Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies.
Kreitman RJ
BioDrugs; 2009; 23(1):1-13. PubMed ID: 19344187
[TBL] [Abstract][Full Text] [Related]
8. Critical Issues in the Development of Immunotoxins for Anticancer Therapy.
Kim JS; Jun SY; Kim YS
J Pharm Sci; 2020 Jan; 109(1):104-115. PubMed ID: 31669121
[TBL] [Abstract][Full Text] [Related]
9. Moxetumomab Pasudotox: First Global Approval.
Dhillon S
Drugs; 2018 Nov; 78(16):1763-1767. PubMed ID: 30357593
[TBL] [Abstract][Full Text] [Related]
10. Expression cloning of cDNAs that render cancer cells resistant to Pseudomonas and diphtheria toxin and immunotoxins.
Brinkmann U; Brinkmann E; Pastan I
Mol Med; 1995 Jan; 1(2):206-16. PubMed ID: 8529099
[TBL] [Abstract][Full Text] [Related]
11. Targeted toxins in brain tumor therapy.
Li YM; Hall WA
Toxins (Basel); 2010 Nov; 2(11):2645-62. PubMed ID: 22069569
[TBL] [Abstract][Full Text] [Related]
12. Recombinant antibody fragments and immunotoxin fusions for cancer therapy.
Brinkmann U
In Vivo; 2000; 14(1):21-7. PubMed ID: 10757057
[TBL] [Abstract][Full Text] [Related]
13. Immunotoxins in the treatment of hematologic malignancies.
Kreitman RJ; Pastan I
Curr Drug Targets; 2006 Oct; 7(10):1301-11. PubMed ID: 17073592
[TBL] [Abstract][Full Text] [Related]
14. Preparation of Diphtheria and Pseudomonas Exotoxin A Immunotoxins and Evaluation of Their Cytotoxicity Effect on SK-BR-3, BT-474, and MDA-MB-231 Breast Cancer Cell Lines.
Amoozadeh S; Hemmati M; Farajollahi MM; Akbari N; Tarighi P
Cancer Invest; 2019; 37(10):546-557. PubMed ID: 31597492
[TBL] [Abstract][Full Text] [Related]
15. Bacteria-derived chimeric toxins as potential anticancer agents.
Khoshnood S; Fathizadeh H; Neamati F; Negahdari B; Baindara P; Abdullah MA; Haddadi MH
Front Oncol; 2022; 12():953678. PubMed ID: 36158673
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Resistance to Immunotoxins Containing
Dieffenbach M; Pastan I
Biomolecules; 2020 Jun; 10(7):. PubMed ID: 32630017
[TBL] [Abstract][Full Text] [Related]
17. B3(Fab)-PE38M: a recombinant immunotoxin in which a mutant form of Pseudomonas exotoxin is fused to the Fab fragment of monoclonal antibody B3.
Choe M; Webber KO; Pastan I
Cancer Res; 1994 Jul; 54(13):3460-7. PubMed ID: 8012967
[TBL] [Abstract][Full Text] [Related]
18. Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systems.
Della Cristina P; Castagna M; Lombardi A; Barison E; Tagliabue G; Ceriotti A; Koutris I; Di Leandro L; Giansanti F; Vago R; Ippoliti R; Flavell SU; Flavell DJ; Colombatti M; Fabbrini MS
Microb Cell Fact; 2015 Feb; 14():19. PubMed ID: 25889802
[TBL] [Abstract][Full Text] [Related]
19. Initial characterization of an immunotoxin constructed from domains II and III of cholera exotoxin.
Sarnovsky R; Tendler T; Makowski M; Kiley M; Antignani A; Traini R; Zhang J; Hassan R; FitzGerald DJ
Cancer Immunol Immunother; 2010 May; 59(5):737-46. PubMed ID: 20091030
[TBL] [Abstract][Full Text] [Related]
20. Immunotoxins: is there a clinical value?
Gottstein C; Winkler U; Bohlen H; Diehl V; Engert A
Ann Oncol; 1994; 5 Suppl 1():97-103. PubMed ID: 7826425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
